Primary Record
Nemorubicin
- In stock
- 9,392 g
- Purity
- 99.4 %
- CAS
- 108852-90-0
Compound Identifiers & Properties
- CAS
- 108852-90-0
- PubChem CID
- 65907
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCO[C@@H](C6)OC)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N2CCO[C@H](OC)C2)[C@H](O)[C@H](C)O1
Names & Synonyms
- Nemorubicin
- nemorubicina
- nemorubicine
- nemorubicinum
- Nemorubicinol
- Nemorbicin
- Nemorubicin [INN]
- methoxymorpholinoDX
- 108852-90-0
- Methoxymorpholino-doxorubicin
- Nemorubicin (GMP)
- MMDX
- Methoxymorpholinyl doxorubicin
- MMDOX
- RefChem:165053
- methoxymorpholinyl-doxorubicin
- pnu 152243
- DTXSID6057619
- FCE-23762
- CHEBI:42053
- D0K2CR
- methoxy-morpholinyl-doxorubicin
- Methoxymorpholinyldoxorubicin
- UNII-7618O47BQM
- 7618O47BQM
- Fce 23762
- SCHEMBL24646
- NEMORUBICIN [WHO-DD]
- CTMCWCONSULRHO-UHQPFXKFSA-N
- C32H37NO13
- orb1302833
- PNU152243A
- CHEMBL1232279
- SCHEMBL29388170
- MFCD00871079
- BADC-00088
- DTXCID301508600
- GLXC-05427
- PNU-152243
- AC1L2482
- AMY10326
- CID65907
- (2S)-2-Methoxymorpholinodoxorubicin
- BDBM50633982
- CID:65907
- FCE-23672
- HY-15794G
- ZINC49757291
- AKOS030526068
- C32-H37-N-O13
- ACN-037651
- CS-2020
- PNU-156685
- PNU-156686
- PNU-159682
- AC-37942
- BP-29358
- BP-43667
- HY-15794
- MS-30933
- SID:53789682
- Methoxymorpholinyl doxorubicin hydrochloride
- SID:405116835
- J488.795F
- 2-amino-pyrido[3,2-d]pyrimidin-4(1h)-one
- B1136
- CS-0899274
- NS00120826
- 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN
- 3'-deamino-3'-(2-methoxymorpholin-4-yl)doxorubicin
- A14363
- F84993
- 33952-EP2270008A1
- 33952-EP2275420A1
- 33952-EP2292617A1
- 33952-EP2295055A2
- 33952-EP2295416A2
- 33952-EP2295426A1
- 33952-EP2295427A1
- 33952-EP2298748A2
- 33952-EP2298764A1
- 33952-EP2298765A1
- 33952-EP2305642A2
- 33952-EP2308855A1
- 33952-EP2311453A1
- 3'-deamino-3'-(2(S)-methoxy-4-morpholinyl)doxorubicin
- A855698
- C066998
- BRD-K51911221-001-01-2
- Q27120450
- (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2S)-2-methoxymorpholin-4-yl]-alpha-L-lyxo-hexopyranoside
- (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3,6-trideoxy-3-((S)-2-methoxymorpholino)-alpha-L-lyxo-hexopyranoside
- C000609287
- (7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2R,4S,5S,6S)-5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- Methoxymorpholinyldoxorubicin;PNU-152243;PNU 152243;PNU152243;PNU-152243A
- (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-((2S)-2-methoxymorpholin-4-yl)-alpha-L-lyxo-hexopyranoside
- (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 2,3,6-TRIDEOXY-3-((S)-2-METHOXYMORPHOLINO)-.ALPHA.-L-LYXO-HEXOPYRANOSIDE
- (7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2R,4S,5S,6S)-5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- (8S)-10alpha-[[3-[(2S)-2alpha-Methoxymorpholino]-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8alpha,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
- (8S,10S)-6,8,11-Trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((S)-2-methoxymorpholino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
- (8S,10S)-6,8,11-TRIHYDROXY-10-{[(2R,4S,5S,6S)-5-HYDROXY-4-[(2S)-2-METHOXYMORPHOLIN-4-YL]-6-METHYLOXAN-2-YL]OXY}-8-(2-HYDROXYACETYL)-1-METHOXY-5,7,8,9,10,12-HEXAHYDROTETRACENE-5,12-DIONE
- 10alpha-[[3-[(2S)-2-Methoxy-4-morpholinyl]-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8beta-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
- 5,12-NAPHTHACENEDIONE, 7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-10-((2,3,6-TRIDEOXY-3-((2S)-2-METHOXY-4-MORPHOLINYL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-, (8S,10S)-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-a-Llyxo- hexopyranosyl]oxy]-, (8S,10S)-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(2-methoxy-4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-.alpha.-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
- DMM